HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James Cranley Selected Research

calphostin complex

3/2012The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: implications for neural control of cardiac excitability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James Cranley Research Topics

Disease

1Heart Failure
06/2020
1Congenital Heart Defects (Congenital Heart Defect)
06/2020
1Myocardial Infarction
01/2019
1Mitochondrial Diseases (Mitochondrial Disease)
01/2018
1Bradycardia
03/2012

Drug/Important Bio-Agent (IBA)

1Simendan (Levosimendan)IBA
06/2020
1Troponin IIBA
01/2019
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2018
1calphostin complexIBA
03/2012
1Neuropeptide YIBA
03/2012
1Protein Kinase CIBA
03/2012
1Adrenergic Agents (Adrenergic Drugs)IBA
03/2012
1GalaninIBA
03/2012
1Galanin Receptors (Galanin Receptor)IBA
03/2012
1Metoprolol (Toprol-XL)FDA LinkGeneric
03/2012
1N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA
03/2012
1M40 (M 40)IBA
03/2012
1BIIE 0246IBA
03/2012
1Acetylcholine (Acetylcholine Chloride)FDA Link
03/2012
1Carbachol (Carbastat)FDA Link
03/2012